Companies / Czech Republic
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Walmark To Stimulate Pharmaceutical Business
July 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Czech healthcare firm Walmark is planning a significant expansion of its pharmaceutical division after it reached its strategic goal of becoming the leading manufacturer of nutritional supplements in Central and Eastern Europe (CEE). The company intends to ramp up exports and is looking to penetrate twenty new markets in Western Europe, the Middle East and Asia. BMI is fairly confident that Walmark will be able boost sales of pharmaceuticals and subsequently enjoy higher margins that cannot be provided by supplements.